Search Results - "Rigot, Olivia"

Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes by Chu, Yaya, Milner, Jordan, Lamb, Margaret, Maryamchik, Elena, Rigot, Olivia, Ayello, Janet, Harrison, Lauren, Shaw, Rosemarie, Behbehani, Gregory K, Mardis, Elaine R, Miller, Katherine, Prakruthi Rao Venkata, Lakshmi, Chang, Hsiaochi, Lee, Dean, Rosenthal, Elana, Kadauke, Stephan, Bunin, Nancy, Talano, Julie-An, Johnson, Bryon, Wang, Yongping, Cairo, Mitchell S

“…Abstract Background Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 virus-specific…”
Get full text

Safety and Efficacy of Virus-Specific Cytotoxic T-Lymphocytes Manufactured By the IFN-g Cytokine Capture System for the Treatment of Refractory Adenovirus, Cytomegalovirus, Epstein Barr Virus, and BK Virus Infections in Children, Adolescents and Young Adults after Allogeneic Hematopoietic Stem Cell Transplantation, Solid Organ Transplantation, or with Primary Immunodeficiency (IND# 17449) by Flower, Allyson M., Friedmann, Rachel, Ayello, Janet, Rigot, Olivia, Harrison, Lauren, Morris, Erin, Sturhahn, Meghan, Maryamchik, Elana, Wang, Yongping, O'Donnell, Lynn, Abu-Arja, Rolla, Lee, Dean Anthony, Talano, Julie-An, Johnson, Bryon, Bunin, Nancy, Cairo, Mitchell S

“…Background: Viral infection remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT)…”
Get full text

Manufacture and Immunological Characterization of GMP-Compliant Functional Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs ® Cytokine Capture System by Chu, Yaya, Milner, Jordan, Lamb, Margaret, Maryamchik, Elena, Rigot, Olivia, Ayello, Janet, Harrison, Lauren, Shaw, Rosemarie, Behbehani, Greg K., Mardis, Elaine R., Miller, Katherine E, Venkata, Lakshmi Prakruthi Rao, Chang, Hsiaochi, Lee, Dean Anthony, Rosenthal, Elana Y., Kadauke, Stephan, Bunin, Nancy, Talano, Julie-An, Johnson, Bryon, Wang, Yongping, Cairo, Mitchell S.

“…Background: The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic that has taken…”
Get full text

424 - Safety and Efficacy of Virus-Specific Cytotoxic T-Lymphocytes Manufactured By the IFN-γ Cytokine Capture System for the Treatment of Refractory Adenovirus, Cytomegalovirus, Epstein Barr Virus, and BK Virus Infections in Children, Adolescents and Young Adults after Allogeneic Hematopoietic Stem Cell Transplantation, Solid Organ Transplantation, or with Primary Immunodeficiency (IND# 17449) by Flower, Allyson, Talano, Julie, Ayello, Janet, Rigot, Olivia, Harrison, Lauren, Morris, Erin, Mintzer, Elizabeth, Maryamchick, Elena, Wang, Yongping, O’Donnell, Lynn C., Abu-Arja, Rolla, Lee, Dean A., Johnson, Bryon D, Chu, Julia, Dvorak, Christopher C., Shenoy, Shalini, Bunin, Nancy J., Cairo, Mitchell S.

Get full text

423 - Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System by Chu, Yaya, Lamb, Margaret, Maryamchik, Elena, Rigot, Olivia, Ayello, Janet, Harrison, Lauren, Mintzer, Elizabeth, Shaw, Rosemarie, Behbehani, Gregory, Mardis, Elaine, Miller, Katherine, Rao Venkata, Lakshmi Prakruthi, Chang, Hsiaochi, Lee, Dean A., Rosenthal, Elana Y., Kadauke, Stephan, Bunin, Nancy J., Talano, Julie, Johnson, Bryon D, Wang, Yongping, Cairo, Mitchell S.

Get full text

Safety and Efficacy of Virus-Specific Cytotoxic T-Lymphocytes Manufactured By the IFN-γ Cytokine Capture System for the Treatment of Refractory Adenovirus, Cytomegalovirus, Epstein Barr Virus, and BK Virus Infections in Children, Adolescents and Young Adults after Allogeneic Hematopoietic Stem Cell Transplantation, Solid Organ Transplantation, or with Primary Immunodeficiency (IND# 17449) by Flower, Allyson, Talano, Julie, Ayello, Janet, Rigot, Olivia, Harrison, Lauren, Morris, Erin, Mintzer, Elizabeth, Maryamchick, Elena, Wang, Yongping, O’Donnell, Lynn C., Abu-Arja, Rolla, Lee, Dean A., Johnson, Bryon D, Chu, Julia, Dvorak, Christopher C., Shenoy, Shalini, Bunin, Nancy J., Cairo, Mitchell S.

Get full text

Manufacture, Immunological Characterization and Clinical Response of GMP Grade Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs® Cytokine Capture System by Chu, Yaya, Lamb, Margaret, Maryamchik, Elena, Rigot, Olivia, Ayello, Janet, Harrison, Lauren, Mintzer, Elizabeth, Shaw, Rosemarie, Behbehani, Gregory, Mardis, Elaine, Miller, Katherine, Rao Venkata, Lakshmi Prakruthi, Chang, Hsiaochi, Lee, Dean A., Rosenthal, Elana Y., Kadauke, Stephan, Bunin, Nancy J., Talano, Julie, Johnson, Bryon D, Wang, Yongping, Cairo, Mitchell S.

Get full text

Optimization of Gating of IFN-Gamma Positive Viral Specific Cytotoxic T-Cells (vCTLs) Following Viral Peptivators® Stimulation Utilizing the Cytokine Capture System on the Clinimacs® Prodigy: Quality Control of the Viral CTL Consortium (VIRCTL) by Rigot, Olivia, Ayello, Janet, Fallon, Bernadette, Colon, Lin Marie, Kuhns, Robert, Harrison, Lauren, Shaw, Rosemarie, Fabricatore, Sandra, Gonzalez, Isabel D, Flower, Allyson, Johnson, Bryon D, Wang, Yongping, Cairo, Mitchell S.

Get full text

131 - Feasibility, Safety and Efficacy of Haploidentical Viral Cytotoxic T-Lymphocytes for Children, Adolescents, and Young Adults (CAYA) with Refractory Viral Infections in Primary Immunodeficiencies (PID) Post Solid Organ Transplant (SOT) or Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) by Milner, Jordan, Talano, Julie-An, Harrison, Lauren, Ayello, Janet, Flower, Allyson, Chu, Yaya, Rigot, Olivia, Johnson, Bryon D, Li, Yimei, Lee, Dean Anthony, Abu-Arja, Rolla, Chu, Julia, Dvorak, Christopher C., O’Donnell, Lynn C., Wang, Yongping, Bunin, Nancy J., Cairo, Mitch S.

Get full text

Feasibility, Safety and Efficacy of Haploidentical Viral Cytotoxic T-Lymphocytes for Children, Adolescents, and Young Adults (CAYA) with Refractory Viral Infections in Primary Immunodeficiencies (PID) Post Solid Organ Transplant (SOT) or Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) by Milner, Jordan, Talano, Julie-An, Harrison, Lauren, Ayello, Janet, Flower, Allyson, Chu, Yaya, Rigot, Olivia, Johnson, Bryon D, Li, Yimei, Lee, Dean Anthony, Abu-Arja, Rolla, Chu, Julia, Dvorak, Christopher C., O’Donnell, Lynn C., Wang, Yongping, Bunin, Nancy J., Cairo, Mitch S.

Get full text

Safety and Efficacy of GMP Clinical Grade Manufacturing of Virus Specific Cytotoxic T Lymphocytes (vCTLS) Against Cytomegalovirus (CMV), Epstein Barr Virus ( EBV), Adenovirus (ADV) and BKV to Treat Medically Refractory Viral Infections Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Children, Adolescents and Young Adults (CAYA) (IND# 17449) by Ayello, Janet, Flower, Allyson, Kuhns, Robert, Colon, Lin Marie, Fallon, Bernadette, Rigot, Olivia, Shaw, Rosemarie, Harrison, Lauren, Morris, Erin, Sturhahn, Meghan, Gonzalez, Isabel D, Wang, Yongping, O’Donnell, Lynn C., Lee, Dean Anthony, Talano, Julie-An, Johnson, Bryon D, Bunin, Nancy J., Cairo, Mitchell S.

Get full text

Enrichment of CD34+ Hematopoietic Progenitor STEM CELLS and Depletion of CD3 CELLS Utilizing the Clinimacs®: Comparison of Immediate Versus Next Day Processing by Rigot, Olivia Caunday, Ayello, Janet, Colon, Lin Marie, Kuhns, Ed, Wade, Cheryl, Shaw, Rosemarie, Harrison, Lauren, Fabricatore, Sandra, Sturhahn, Meghan, Kretschmer, Patricia, McHale, Patricia, Flower, Allyson, Liu, Delong, Seiter, Karen, Cairo, Mitchell S.

“…There is an increase in utilizing matched unrelated donors (MUD) & haploidentical donors over the past 20 years (Cairo et al, Biol Blood and Marrow Transplant,…”
Get full text